Psychiatrist

Dr. Mort Rubinstein, MD

423 E 23rd St, New York, New York, 10010-5011

About Dr. Mort Rubinstein

Dr. Mort Rubinstein is a psychiatrist based in New York, New York who is specialized in Psychiatry. Active license number of Dr. Mort Rubinstein is 142435 for Psychiatry in New York. His current practice location is 423 E 23rd St, New York. Patients can contact him at 212-686-7500 or can fax him at 212-951-3356. Dr. Mort Rubinstein, MD, specializes in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1326094152.

Dr. Mort Rubinstein specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Dr. Mort Rubinstein's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Dr. Mort Rubinstein
Specialization Psychiatry
Credentials MD
Gender Male
Practice Address: 423 E 23rd St,
New York, NY - 10010-5011
Fax 212-951-3356

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1326094152
NPI Enumeration Date: 25 May, 2006
NPI Last Update On: 10 Dec, 2007

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Dr. Mort Rubinstein are as mentioned below.

License NumberSpecializationStateStatus
142435Psychiatry New YorkPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Dr. Mort Rubinstein
162 Hidden Ridge Dr,
Syosset, NY - 11791-4316

Book an Appointment with Dr. Mort Rubinstein

To schedule an appointment, contact Dr. Mort Rubinstein at 423 E 23rd St, New York, New York or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Dr. Mort Rubinstein:

Dr. Mort Rubinstein is a psychiatrist specializing in Psychiatry. He specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Dr. Mort Rubinstein is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Dr. Mort Rubinstein practices at 423 E 23rd St, New York, New York, 10010-5011.

To schedule an appointment with Dr. Mort Rubinstein, please contact the office at 212-686-7500.

Reviews & Feedback

Have you visited Dr. Mort Rubinstein? Share your experience to help others looking for a psychiatrist in New York, NY.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.